Expertise in
11
conditions

Wilhelm Woessmann

Hamburg, HH, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
11
conditions
Hamburg, HH, DE 

Overview

Wilhelm Woessmann practices practicing medicine in Hamburg, Germany.

Mr. Woessmann is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Anaplastic Large Cell Lymphoma, T-Cell Lymphoma, Burkitt Lymphoma, Bone Marrow Transplant, and Small Bowel Resection.

He is actively involved in clinical research, co-authoring 120 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Hamburg, HH, Germany
Other Locations
Giessen, HE, Germany
Eppendorf, HH, Germany
Mutlangen, BW, Germany
Frankfurt Am Main, HE, Germany
Muenster, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: September 04, 2026
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Study Phase: Phase 3
View 1 Less Clinical Trial

120 Total Publications

Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R.
Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R.
Journal: Blood advances
Published: January 02, 2026

Frequently Asked Questions about Wilhelm Woessmann

Is Wilhelm Woessmann a top-rated expert for Anaplastic Large Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Wilhelm Woessmann is classified as an Elite expert for Anaplastic Large Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wilhelm Woessmann participate in research or clinical trials?

Yes. Wilhelm Woessmann has published 120 articles and abstracts on conditions like Anaplastic Large Cell Lymphoma. You can view a list of Wilhelm Woessmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Woessmann's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile